Any therapeutic drug used for a disease whose pathology does not relate to DNA would bind with DNA anyway. In this case, is it desirable that the drug should be groove binder or intercalator so as to cause minimum alteration in DNA?

More Prayasee Baruah's questions See All
Similar questions and discussions